A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I–IIIA (1988) uterine papillary serous carcinoma of the endometrium

Overview of attention for article published in Gynecologic Oncology, February 2013

Altmetric Badge

Mentioned by

f1000: 1 research highlight platform

Readers on

mendeley: 46 Mendeley

You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Article details
Title	A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I–IIIA (1988) uterine papillary serous carcinoma of the endometrium
Published in	Gynecologic Oncology, February 2013
DOI	10.1016/j.ygyno.2013.01.025
Pubmed ID	23385150
Authors	Anuja Jhingran, Lois M. Ramondetta, Diane C. Bodurka, Brian M. Slomovitz, Jubilee Brown, Lawrence B. Levy, Michael E. Garcia, Patricia J. Eifel, Karen H. Lu, Thomas W. Burke
Abstract	To prospectively evaluate tumor control, survival, and toxic effects in patients with International Federation of Gynecology and Obstetrics (1988) stage I-IIIA papillary serous carcinoma of the endometrium treated with concurrent chemoradiation and adjuvant chemotherapy.

View on publisher site Alert me about new mentions

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline

Activity

Mendeley demographics

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country	Count	As %
Turkey	1	2%
Unknown	45	98%

Demographic breakdown

Readers by professional status
Readers by professional status	Count	As %
Student > Ph. D. Student	6	13%
Other	5	11%
Student > Doctoral Student	4	9%
Student > Master	4	9%
Researcher	3	7%
Other	11	24%
Unknown	13	28%

Readers by discipline
Readers by discipline	Count	As %
Medicine and Dentistry	20	43%
Agricultural and Biological Sciences	3	7%
Biochemistry, Genetics and Molecular Biology	2	4%
Mathematics	1	2%
Nursing and Health Professions	1	2%
Other	4	9%
Unknown	15	33%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2013.

All research outputs

#17,286,379

of 25,374,647 outputs

Outputs from Gynecologic Oncology

#3,823

of 4,956 outputs

Outputs of similar age

#194,085

of 291,554 outputs

Outputs of similar age from Gynecologic Oncology

#24

of 38 outputs

Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.

So far Altmetric has tracked 4,956 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 291,554 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.

We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.